Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.54 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.54 |
| ▸ | ATM | Q13315 | 3/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.46 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.46 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.44 |
| ▸ | MYC | P01106 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | CDC25B | P30305 | 1/20 | 0.42 |
| ▸ | DAO | P14920 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9622204 | 0.90 | AKR1C3 (0.53) | ALDH1A1AKR1C3ATMTDP1L3MBTL1 | |
| SCHEMBL28170524 | 0.88 | ALDH1A1 (0.55) | ALDH1A1AKR1C3ATMTDP1L3MBTL1 | |
| SCHEMBL27321464 | 0.87 | AKR1C3 (0.46) | ALDH1A1AKR1C3ATMTDP1L3MBTL1 | |
| SCHEMBL27900422 | 0.87 | ALDH1A1 (0.60) | ALDH1A1AKR1C3ATMTDP1L3MBTL1 | |
| SCHEMBL31672209 | 0.84 | AKR1C3 (0.68) | ALDH1A1AKR1C3ATMTDP1L3MBTL1 | |
| SCHEMBL78316 | 0.84 | AKR1C3 (0.68) | ALDH1A1AKR1C3ATMTDP1L3MBTL1 | |
| SCHEMBL857849 | 0.84 | AKR1C3 (0.67) | ALDH1A1AKR1C3ATMTDP1L3MBTL1 | |
| SCHEMBL9712438 | 0.84 | CLCN2 (0.43) | ALDH1A1AKR1C3ATMTDP1L3MBTL1 | |
| SCHEMBL9712358 | 0.82 | ELANE (0.42) | ALDH1A1AKR1C3ATMTDP1L3MBTL1 | |
| SCHEMBL11652453 | 0.82 | AKR1C3 (0.42) | ALDH1A1AKR1C3ATMTDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0754189-B1 | RECEPTOR MODULATING AGENTS AND METHODS RELATING THERETO | RECEPTAGEN CORP (US) | 2002-10-09 | — | — | EP | disclosed |
| EP-1015475-A1 | VITAMIN B 12? RECEPTOR MODULATING AGENTS AND METHODS RELATED THERETO | RECEPTAGEN CORPORATION (US) | 2000-07-05 | — | — | EP | disclosed |
| US-6083926-A | AGENT COMPRISED OF VITAMIN B12 COVALENTLY COUPLED TO BIOTIN BY WATER-SOLUBLE LINKER | THE UNIVERSITY OF WASHINGTON (US) | 2000-07-04 | — | — | US | disclosed |
| US-5869465-A | BINDING TO CELL SURFACE RECEPTORS AND AFFECTING THEIR TRAFFICKING PATHWAY FOR THE TREATMENT AND DIAGNOSIS OF DISORDERS IN WARM-BLOODED ANIMALS | RECEPTAGEN CORPORATION (US) | 1999-02-09 | — | — | US | disclosed |
| US-5840712-A | TARGETS AND LINKERS | RECEPTAGEN CORPORATION (US) | 1998-11-24 | — | — | US | disclosed |
| US-5840880-A | VITAMIN B12 DIMER | RECEPTAGEN CORPORATION (US) | 1998-11-24 | — | — | US | disclosed |
| US-5739287-A | BOUND ALSO TO A RECEPTOR MODULATING AGENT TO IMPEDE CELL SURFACE RECEPTOR TRAFFICKING PATHWAYS BY INHIBITING THE RECYCLING OF RECEPTORS TO THE CELL SURFACE; ANTITUMOR AND -CARCINOGENIC AGENTS; LEUKEMIA | UNIVERSITY OF WASHINGTON (US) | 1998-04-14 | — | — | US | disclosed |
| WO-1997014711-A9 | VITAMIN B12 RECEPTOR MODULATING AGENTS AND METHODS RELATED THERETO | — | 1997-10-02 | — | — | WO | disclosed |
| WO-1997014711-A1 | VITAMIN B12 RECEPTOR MODULATING AGENTS AND METHODS RELATED THERETO | RECEPTAGEN CORPORATION (US) | 1997-04-24 | — | — | WO | disclosed |
| EP-0754189-A1 | RECEPTOR MODULATING AGENTS AND METHODS RELATING THERETO | RECEPTAGEN CORPORATION (US) | 1997-01-22 | — | — | EP | disclosed |
| WO-1995027723-A1 | RECEPTOR MODULATING AGENTS AND METHODS RELATING THERETO | RECEPTAGEN CORPORATION (US) | 1995-10-19 | — | — | WO | disclosed |